20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T8555 | Neuraminidase-IN-1 | Novel NA Inhibitor,Compound Y-1 | Others , Influenza Virus |
Neuraminidase-IN-1 (Compound Y-1) is a novel neuraminidase inhibitor. | |||
T8506 | THPP-1 | PDE | |
THPP-1 is a potent and orally bioavailable inhibitor of PDE10A(Ki of 1 nM and 1.3 nM for human and rat PDE10A, respectively). | |||
T9223 | RO-0335 | Reverse Transcriptase | |
RO-0335 is a potent diphenylether nonnucleoside reverse transcriptase inhibitor. RO-0335 inhibits Wt HIV-1 (IC50 = 1.1 nM) and retained activity (IC50< 100 nM) against 92% of a large number of NNRTI-resistant clinical is... | |||
TNU1448 | novelN4-Benzoyl-7’-O-(4,4’-dimethoxytrityl oxy)morpholinocytosine | ||
Nucleoside Derivatives - Morpholino nucleosides | |||
T15239 | Epristeride | SKF105657,ONO-9302 | Others |
Epristeride is a novel inhibor of 5α-reductase. | |||
T4522 | SSD114 HCl | GABA Receptor | |
SSD114 is a novel GABAB receptor positive allosteric modulator. | |||
T34782 | Tamolarizine | Tamolarizine,Tamolarizine HCl,Tamolarizine free base,NC 1100,NC1100,Tamolarizine dihyrchloride,NC-1100 | Calcium Channel |
Tamolarizine (Tamolarizine free base) free base is a novel calcium antagonist. | |||
T8268 | 6,2'-Dihydroxyflavone | GABA Receptor | |
6,2'-Dihydroxyflavone is a novel antagonist of GABAA receptor. | |||
T35180 | Ximoprofen | Ximoprofeno,Ximoprofenum | Others |
Ximoprofen is a novel anti-inflammatory compound for the study of spondylitis. | |||
T39746 | DNDI-6148 | ||
DNDI-6148 is a novel preclinical candidate for the treatment of visceral leishmaniasis. | |||
T19840 | GSK-F1 | PI4KA inhibitor-F1 | PI4K |
GSK-F1 (PI4KA inhibitor-F1) is a novel potent PI4KA inhibitor. | |||
T3917 | Protopanaxatriol | 20(R)-APPT,20(R)-Protopanaxatriol,(20R)-Protopanaxatriol | PPAR |
Protopanaxatriol (20(R)-APPT), a major ginseng constituent, is a novel PPARγ antagonist. | |||
T27250 | Elarofiban | RWJ-53308,RWJ 53308,RWJ53308 | Integrin |
Elarofiban(RWJ-53308) is a novel and orally active GPIIb/IIIa antagonist. | |||
T39573 | GSK251 | PI3K | |
GSK251 is a novel, orally bioavailable inhibitor of PI3Kδ, exhibiting high potency and selectivity, with a unique binding mode. | |||
T14863 | Carabersat | SB 204269 | Others |
Carabersat(SB 204269) is a novel and effective anticonvulsant and antiepileptic agent. | |||
T27159 | DF-1111301 | DF1111301,DF 1111301 | Platelet aggregation , Histamine Receptor |
DF-1111301 is a novel anti-allergic compound with anti-histamine H1 and anti-PAF activity. | |||
T33422 | MK-0873 | MK 0873,MK0873 | PDE |
MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor. | |||
T15564 | IMD-0560 | IκB/IKK | |
IMD-0560 is a novel inhibitor of IκB kinase β. | |||
T19379 | Ipsalazide | Autophagy | |
Ipsalazide is a novel salicylazosulfapyridine analog for the treatment of inflammatory bowel disease. | |||
T1897 | MDL-29951 | NMDAR , iGluR | |
MDL-29951 is a novel glycine antagonist of NMDA receptor activation. |